Search company, investor...
Accuray company logo




Total Raised


Date of IPO


Market Cap


Stock Price


About Accuray

Accuray Incorporated (Nasdaq: ARAY) is a radiation oncology company that develops, manufactures, and sells precise treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The company's technologies deliver the full range of radiation therapy and radiosurgery treatments.

Headquarters Location

1310 Chesapeake Terrace

Sunnyvale, California, 94089,

United States

+1 408 716 4600

Missing: Accuray's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Accuray's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Accuray

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Accuray is included in 1 Expert Collection, including Medical Devices.


Medical Devices

3,501 items - excludes those without working websites.

Accuray Patents

Accuray has filed 206 patents.

The 3 most popular patent topics include:

  • Medical physics
  • Radiation therapy
  • Radiobiology
patents chart

Application Date

Grant Date


Related Topics




Radiation therapy, Medical physics, Particle physics facilities, Radiobiology, Global Positioning System


Application Date


Grant Date



Related Topics

Radiation therapy, Medical physics, Particle physics facilities, Radiobiology, Global Positioning System



Latest Accuray News

Global Radiation Therapy Market Report 2023: Featuring Ion Beam Applications, Siemens Healthineers, Accuray, Elekta, ViewRay & Hitachi

May 30, 2023

News provided by Share this article Share this article The global radiation therapy market is expected to reach US$13.28 billion in 2027, witnessing growth at a CAGR of 6.77%, over the period 2023-2027. Factors such as surging incidence of cancer cases, rising healthcare expenditure, upsurge in economic growth, growing aging population and expanding urbanization are expected to drive the market. The growth of the market would be challenged by severe side effects of the therapy and stringent regulations and barriers to implementation. A few notable trends may include increasing public awareness, rising preference towards non-invasive procedures and advancements in technology. The global radiation therapy market can be categorized into external beam radiation therapy, internal beam radiation therapy and others (systemic radiotherapy) on the basis of type. Further, the external beam radiation therapy market is segmented on the basis of type and devices. Depending upon the type, the global external beam radiation therapy market can be categorized into following categories: Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), Tomotherapy, Stereotactic Radiosurgery, Stereotactic Body Radiation Therapy and Proton Therapy. Whereas, on the basis of devices, the global external beam radiation therapy market can be segmented into three categories, named as, LINAC (Linear Accelerators), proton beam therapy devices and compact advanced therapy devices. The fastest growing regional market is North America due to continuous inclination to the usage of novel technologies, rising disposable income and healthcare expenditure in the region and rising awareness about procedures and sophisticated diagnostic techniques. Europe represents the second largest radiation therapy market and is already well-penetrated at developed market levels. The market for radiation oncology has been negatively impacted due to the COVID-19 pandemic. Hospitals delayed the purchase of capital equipment and redirected the resources towards the treatment of COVID-19. Scope of the report The report provides a comprehensive analysis of the global radiation therapy market segmented on the basis of type. The major regional and country markets (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) have been analyzed. The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth. The competitive landscape of the market, along with the company profiles of leading players (Ion Beam Applications SA, Siemens Healthineers AG, Accuray Inc., Elekta AB, ViewRay, Inc. and Hitachi Ltd.) are also presented in detail. Key Target Audience End Users (Hospitals, Cancer Research Institutes and Ambulatory & Radiotherapy Centers) Government Bodies & Regulating Authorities

Accuray Frequently Asked Questions (FAQ)

  • Where is Accuray's headquarters?

    Accuray's headquarters is located at 1310 Chesapeake Terrace, Sunnyvale.

  • What is Accuray's latest funding round?

    Accuray's latest funding round is IPO.

  • How much did Accuray raise?

    Accuray raised a total of $17.21M.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.